deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04653688

Markers of Disease Progression and Gait Within the Parkinsonian Population (Gait'N'Park)

A Prospective Study on Markers of Disease Progression and Gait Within the Parkinsonian Population

Sponsor: FeetMe

Updated 6 times since 2021 Last updated: Dec 3, 2025 Started: Dec 22, 2020 Primary completion: Oct 17, 2024 Completion: Oct 17, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Parkinson Disease, this trial is completed. The trial is conducted by FeetMe and has accumulated 6 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotNot Yet Recruiting~Apr 2022 – ~Mar 2024 · 23 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2026 · 16 months · monthly snapshotUnknown~Jan 2026 – present · 6 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Jan 2026 — Present [monthly]

    Completed NA

    Status: UnknownCompleted

  2. Sep 2024 — Jan 2026 [monthly]

    Unknown NA

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown StatusUnknown

  4. Mar 2024 — Jul 2024 [monthly]

    Unknown Status NA

    Status: RecruitingUnknown Status

  5. Apr 2022 — Mar 2024 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

Show 1 earlier version
  1. Jan 2021 — Apr 2022 [monthly]

    Not Yet Recruiting NA

    First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • FeetMe
  • France Parkinson Association
  • H. Lundbeck A/S
  • University Hospital, Lille
  • Vaincre Parkinson
Data source: University Hospital, Lille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations